Maxalt Side Effects

Although most people have no problems with Maxalt, side effects are possible, such as dizziness, drowsiness, and nausea. In many cases, side effects are mild and easily treated by you or your healthcare provider. However, there are some more serious side effects that you should report to your healthcare provider, including severe chest pain or tightness; shortness of breath; or a sudden, severe abdominal pain.

Maxalt Side Effects: An Introduction

As with any medicine, side effects are possible with Maxalt® (rizatriptan benzoate). However, not everyone who takes it will have problems. In fact, most people tolerate the medicine well. If people do develop side effects, in most cases, they are minor, meaning they require no treatment or are easily treated by you or your healthcare provider.
 
(This article covers many, but not all, of the possible side effects with Maxalt. Your healthcare provider can discuss a more complete list of Maxalt side effects with you.)
 

Common Side Effects of Maxalt

Maxalt has been studied thoroughly in clinical trials. In these studies, the side effects that occur in a group of people taking the drug are documented and compared to those that occur in another group of people not taking the medicine. This way, it is possible to see what side effects occur, how often they appear, and how they compare to the group not taking the medicine.
 
Based on these studies, some of the most common side effects of Maxalt include:
 
  • Dizziness -- in up to 9 percent of people
  • Drowsiness -- up to 8 percent
  • Fatigue or weakness -- up to 7 percent
  • Nausea -- up to 6 percent
  • Abnormal sensations, such as tingling, burning, or pricking (paresthesia) -- up to 4 percent
  • Chest pain, including chest tightness, chest pressure, or chest heaviness -- up to 3 percent
  • Dry mouth -- up to 3 percent
  • Neck pain, jaw pain, or throat pain -- up to 2 percent.
     
(Maxalt Side Effects Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation